Folic acid functionalization for targeting self-assembled paclitaxel-based nanoparticles

Area of Science:

• Nanotechnology
• Drug Delivery Systems
• Bioconjugation Chemistry

Background:

• Targeted drug delivery aims to enhance therapeutic efficacy and reduce side effects.
• Folic acid receptors are overexpressed on various cancer cells, making them attractive targets.
• Paclitaxel is a potent chemotherapeutic agent with broad-spectrum activity.

Purpose of the Study:

• To synthesize and characterize hetero-nanoparticles self-assembled from folic acid-conjugated and paclitaxel-conjugated components.
• To investigate the impact of varying folic acid conjugate percentages on nanoparticle properties and biological activity.
• To evaluate the therapeutic potential of these targeted drug delivery systems.

Main Methods:

• Synthesis of hetero-nanoparticles via self-assembly of functionalized conjugates.
• Characterization of nanoparticle size, morphology, and drug loading.
• In vitro biological activity assays to determine efficacy and targeting specificity.

Main Results:

• Successful self-assembly of hetero-nanoparticles incorporating both folic acid and paclitaxel.
• Demonstrated correlation between folic acid content and nanoparticle characteristics.
• Significant biological activity observed, indicating effective drug delivery and targeting.

Conclusions:

• Hetero-nanoparticles offer a promising platform for targeted delivery of paclitaxel.
• The tunable composition allows for optimization of nanoparticle performance.
• These findings support the development of novel cancer therapeutics.